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Background: Diabetic nephropathy is the leading cause of end stage renal disease. All three cell types of the
glomerulus, podocytes, endothelial cells and mesangial cells, play important roles in diabetic nephropathy. In this
report we used Meis1-GFP transgenic mice to purify mesangial cells from normal mice and from db/db mice, which
suffer diabetic nephropathy. The purpose of the study is to better define the unique character of normal mesangial
cells, and to characterize their pathogenic and protective responses during diabetic nephropathy.
Methods: Comprehensive gene expression states of the normal and diseased mesangial cells were defined with
microarrays. By comparing the gene expression profiles of mesangial cells with those of multiple other renal cell
types, including podocytes, endothelial cells and renal vesicles, it was possible to better define their exceptional
nature, which includes smooth muscle, phagocytic and neuronal traits.
Results: The complete set of mesangial cell expressed transcription factors, growth factors and receptors were
identified. In addition, the analysis of the mesangial cells from diabetic nephropathy mice characterized their
changes in gene expression. Molecular functions and biological processes specific to diseased mesangial cells were
characterized, identifying genes involved in extracellular matrix, cell division, vasculogenesis, and growth factor
modulation. Selected gene changes considered of particular importance to the disease process were validated and
localized within the glomuerulus by immunostaining. For example, thrombospondin, a key mediator of TGFβ
signaling, was upregulated in the diabetic nephropathy mesangial cells, likely contributing to fibrosis. On the other
hand the decorin gene was also upregulated, and expression of this gene has been strongly implicated in the
reduction of TGFβ induced fibrosis.
Conclusions: The results provide an important complement to previous studies examining mesangial cells grown
in culture. The remarkable qualities of the mesangial cell are more fully defined in both the normal and diabetic
nephropathy diseased state. New gene expression changes and biological pathways are discovered, yielding a
deeper understanding of the diabetic nephropathy pathogenic process, and identifying candidate targets for the
development of novel therapies.
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The glomerulus is composed of three main cell types,
podocytes, endothelial cells and mesangial cells. Mesan-
gial cells provide the extracellular matrix framework
upon which the glomerulus is built. In addition they
have smooth muscle-like properties and are able to regu-
late capillary flow. Mesangial cells also have a phagocytic
function, and are capable of carrying out disposal and
degradation of filtrate debris.
Mesangial cells play important roles in many kidney
diseases, including diabetic nephropathy. Type2 diabetes
is showing increasing global prevalence and is now the
most common cause of end stage renal disease [1]. All
three major cell types of the glomerulus have been
implicated in diabetic nephropathy. The mesangial cells
are responsible for the observed accumulation of extra-
cellular matrix and mesangial expansion [2].
Because of their remarkable properties mesangial cells
have been the subject of intense investigation. In par-
ticular, many studies have used microarrays to better
understand these cells. In most of these studies mesan-
gial cells were grown in culture and exposed to treat-
ments relevant to various disease conditions, and the
resulting changes in gene expression profiles were deter-
mined with microarrays. Treatments included high glu-
cose [3], static pressure [4], serum [5], kynurenine
metabolites [6], endothelin [7] and PDGF [8]. The
results defined the multiple gene expression responses
of mesangial cells to these stimuli, and thereby provided
insight into the molecular mechanisms of mesangial cell
mediated pathogenesis. These studies were limited, how-
ever, by the use of mesangial cells in culture, which can-
not fully replicate the in vivo cell, and by the restricted
sets of treatments, which cannot completely reproduce
the complex micro-environmental changes experienced
by mesangial cells during diabetic nephropathy.
In this report we define in vivo mesangial cell gene ex-
pression programs during health and disease. The
Meis1-GFP transgene specifically marks mesangial cells
within the glomerulus, allowing their purification
through fluorescence activated cell sorting (FACS), and
subsequent gene expression profiling with microarrays.
By comparing the mesangial gene expression pattern to
those of other renal cell types it was possible to begin to
define the unique character of these remarkable cells. In
addition we purified mesangial cells from db/db mutant
mice with diabetic nephropathy, allowing the determin-
ation of both pathogenic and protective changes in gene
expression as a function of disease.
Methods
Purification of mesangial cells
Meis1-GFP transgenic mice, Tg(Meis1-EGFP)FO156Gsat,
were obtained from GENSAT/MMRC (http://www.gensat.org/MMRRC_report.jsp). The Meis1-GFP marks
both stromal (interstitial) cells and mesangial cells, so it
was essential to first purify glomeruli, to remove stroma.
Glomeruli were isolated by sieving, a single cell suspen-
sion made, and mesangial cells FACS sorted as previ-
ously described [9]. The db/db Meis1-GFP mice were
made by crossing db/+ and db/+ Meis1-GFP mice, with
one eighth of progeny giving the desired genotype.
This study was carried out in strict accordance with
the recommendations of the Guide for the Care and Use
of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Cincinnati
Children's Research Foundation Institutional Animal
Care and Use Committee (protocol number 0D02013).
Purity
The microarray data was analyzed to insure the purity of
the mesangial cells. As described in Results we screened
for podocyte specific genes and found several that
showed low, near background, expression in the mesan-
gial cell profiles, arguing for very limited podocyte con-
tamination. A similar analysis of genes associated with
endothelial cells was performed giving similar results.
The endothelial specific markers Pecam1, KDR, Tspan8,
Plac8 and Eltd1 all showed strong expression in endo-
thelial cells, as expected, and very low expression in the
mesangial cells. It is interesting to note, however, that
some endothelial specific marker genes did show signifi-
cant expression in the mesangial cells. For example Tek,
also known as Tie2, showed expression levels of about
3,000 in the glomerular endothelial cells, but also a con-
siderable expression level of about 1,000 in mesangial
cells. We argue that this is not the result of contamin-
ation since other endothelial cell markers showed low
expression in the mesangial cells, but rather reflected a
partial endothelial phenotype for the mesangial cells. We
also examined the expression data for the presence of
marker genes from other compartments of the kidney.
For example Ace, Acsm1, Aqp11, Slc18a1, Slc22a6 and
Spp2 all should show restricted expression in the prox-
imal tubule of the kidney [10], and each showed very
low expression levels in the mesangial cells.
RNA purification and Target Amplification
RNA was purified using Qiagen RNeasy Micro Kits. Tar-
get amplifications were carried out using RiboSpia tech-
nology from Nugen, with the Ovation Pico WTA
system. Affymetrix standard methods were used for car-
rying out microarray hybridizations, washes and scans.
Array data analysis
Data was analyzed primarily using Agilent GeneSpring
11.5.1 software. Specific parameters are described in
Results. In addition we used ToppGene (http://toppgene.
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org/) [12] and Cytoscape (http://www.cytoscape.org/)
[13] for functional analysis and preparation of figures.
Microarray data is available on the public resource
GUDMAP (www.gudmap.org).Results and discussion
The unique gene expression character of the
mesangial cell
Mice with the BAC Meis1-GFP transgene show specific
GFP labeling of both stromal and mesangial cells in the
kidney [10]. It was therefore possible to isolate a very
pure population of mesangial cells from adult mouse
kidneys by first purifying the glomeruli, using a sieving
procedure, followed by preparation of a single cell sus-
pension and FACS sorting of the GFP positive mesangial
cells. Samples were prepared in biological triplicate, and
gene expression profiles defined using Affymetrix Mouse
Gene 1.0 ST microarrays.
To better understand the unique character of mesan-
gial cells we contrasted their gene expression patterns to
those of other cell types, including podocytes, endothe-
lial cells, kidney capsule, total kidney cortex, renal vesi-
cles, and cap mesenchyme. The end result was a list of
172 genes with distinctively elevated expression in
mesangial cells (Additional file 1: Table S1). A heat map
showing the relative expression levels of these genes is
shown in Figure 1. (See Additional file 2: Figure S1 for
an expandable heat map with genes named). We used
the human protein atlas (http://www.proteinatlas.org/)
to confirm expression of twenty eight genes predicted by
the microarray data to have elevated mesangial cell ex-
pression (Figure 2).
To begin to determine the molecular functions and
biological processes associated with these genes we used
ToppGene (http://toppgene.cchmc.org/). Some of the
strongest statistical hits for biological processes, with
P-values of essentially zero, were found for wound healing,
coagulation, locomotion, regulation of body fluid levels,
and muscle contraction. Other biological processes of
interest included inflammatory processes, ossification, cell
adhesion, and extracellular matrix organization. Quite
striking, there was also a gene expression signature of
neural character, including behavior, cognition, learning,
axogenesis, and neuron development. The picture that
emerges describes a remarkable cell type with a markedly
diverse set of biological functions. For complete lists see
Additional file 3: Table S2.
The results can be presented diagrammatically as
cytoscapes (Figure 3). The center hexagons represent
some of the genes with mesangial elevated expression,
and the surrounding squares are color coded to show
molecular functions, biological processes, transcriptionfactors and microRNAs strongly associated with the
connected genes.Transcription factors
Transcription factors play a key role in determining cell
identity. The screen identified fourteen transcription fac-
tor genes with significantly elevated expression in
mesangial cells, including Gata3, Mecom, Pawr, Arid5b,
Zeb2, Ets1, Apbb2, Snai2, Klf12, Hopx, Hdac9, Nr2f1,
Ebf1 and Rybp, as ranked according to expression level.
It has been previously shown that Gata3 is selectively
expressed in the ureteric bud as well as mesangial cells
and their adjacent endothelial cells during kidney devel-
opment. GATA3 haploinsufficiency in humans causes
hypoparathryoidism, sensineural deafness and renal
anomalies, including aplasia, dysplasia and hypoplasia
[14].
Mecom, also known as Evi1, encodes a zinc finger
transcription factor. It is intriguing to note that
MECOM has been shown to physically interact with
GATA protein, and it has also been shown to inhibit in-
duction of some TGFβ target genes, and to play roles in
cell proliferation and apoptosis [15].
The PAWR leucine zipper protein was shown to
sensitize cells to apoptotic signals and was originally
identified as a gene induced in apoptotic prostate cancer
cells [16]. Of interest, given mesangial cell function in
the synthesis of extracellular matrix, PAWR has also
been shown to regulate secretase cleavage of amyloid
precursor protein, and has thereby been implicated in
Alzheimer disease [17]. PAWR was also shown to inter-
act with WT1 and to enhance its transcriptional repres-
sion activity [18]. This might seem irrelevant since Wt1
is generally though to be associated with podocytes, and
not mesangial cells. We observed very robust expression
of Pawr in mesangial cells, and about a three fold lower
level in podocytes. Of considerable interest, however, we
also observed an inverse gene expression pattern for
Wt1, with raw signal expression in podocytes of about
3400, and a lower but still strong expression level of
about 650 in mesangial cells.
This surprisingly suggests that Wt1 is expressed in
mesangial cells as well as podocytes. Could this be due
to contamination of the mesangial cells with podocytes?
We tested the data for possible contamination by exam-
ining the mesangial gene expression profile for other
genes thought to be podocyte specific. If they all showed
significant expression in the putative mesangial cells
then this would argue strongly in favor of contamin-
ation. If, on the other hand, some are indeed truly podo-
cyte specific in the dataset then this would rule out
contamination as an explanation. It is difficult to envis-
age a scenario where the transcripts of some podocyte
Figure 1 Heatmap showing genes with elevated expression
in normal mesangial cells. Expression patterns of 172 genes with
up-regulation in mesangial cells are compared across multiple renal
compartments, including cap mesenchyme, renal vesicle, total renal
cortex, podocytes, endothelial cells and renal capsule. Red indicates
high, yellow represents intermediate and blue indicates low gene
expression level. Most of the 172 genes are not uniquely expressed
in mesangial cells, but do show significantly elevated mesangial
expression. For an image that can be zoomed to visualize gene
names see Additional file 2: Figure S1.
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others did not.
Further analysis of the data indicated that contamin-
ation could not explain the observed Wt1 expression in
mesangial cells. Several genes, including Podxl, Nphs1
and Nphs2 showed strongly podocyte specific expres-
sion, as expected, and very low expression levels in
mesangial cells. For example, Nphs2 gave raw signal
levels of approximately 5,000 in podocytes, but only
about 100 in mesangial cells.
The APBB2 protein, similar to PAWR , was shown to
bind to amyloid precursor protein (APP)[19]. It is inter-
esting to note that the gene encoding APP shows strong
expression in mesangial cells, with raw signal levels over
4,000, but is also widely and strongly expressed in the
other cell types examined, including podocytes and
endothelial cells. Apbb2 has also been shown to be a
regulator of programmed cell death [20].
The ARID5B transcription factor has been previously
shown to be able to drive smooth muscle development
when over expressed in 3T3 fibroblasts [21]. Its strong
expression in mesangial cells likely reflects their smooth
muscle character. Arid5b mutant mice show severe re-
duction in the number of mesangial cells, as well as their
mis-location at the edge of the glomerulus [22]. Hopx
encodes a divergent homeodomain protein that physic-
ally interacts with SRF and regulates gene expression in
cardiac muscle [23], and could therefore also play a role
in defining the muscle character of mesangial cells.
Zeb2 encodes a 2-handed zinc finger/homeodomain
DNA binding transcriptional repressor that interacts
with activated SMADs and represses cadherin expres-
sion in response to TGFβ signaling [24]. This is of par-
ticular interest since TGFβ is thought to play an
essential role in driving kidney fibrosis during a number
of diseases, including diabetic nephropathy. Decreased
cadherin expression promotes EMT, the production of
fibroblasts, and consequent fibrosis. The Snai2 gene, a
member of the snail family, which encodes transcrip-
tional repressors. Notch signaling can activate Snai2,
promoting resistance to anoikis, and, once again, indu-
cing epithelia to mesenchyme transition through repres-
sion of E-cadherin [25].
Figure 2 Immunohistochemistry showing glomerular expression patterns of some of the genes with elevated mesangial cell
expression. The proteins of some genes, such as Nr2f1, show nuclear localization, as would be expected for a transcription factor, while in other
cases, such as for PREX2, there is a striking extracellular localization. Data is from the human protein atlas (http://www.proteinatlas.org/).
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lial and neural crest cells. It plays a key role in cytokine
signaling [26]. Its expression in mesangial cells reflects a
gene expression signature with significant endothelial
character.
The nuclear receptor Nr2f1 is of interest, as it has
been previously shown to have restricted expression in
the mesangial cells of the adult kidney, again providing
historic validation of the microarray screen.Growth factors
Mesangial cells showed very robust expression of three
growth factor encoding genes, Ptn, Mfge8 and Gdf10.
The Ptn gene, encoding pleiotrophin, was expressed at a
very high level in mesangial cells, with raw signal values
of around 6000. Pleiotrophin is a heparin-binding
growth/differentiation inducing cytokine and is a power-
ful angiogenic factor.PTN receptors include PTPRB, PTRZ, SDC1 and
SDC3. In the prostate PTN has been implicated in the
autocrine regulation of mesenchyme and the paracrine
regulation of epithelia [27]. We observed modest expres-
sion levels of two of these receptor genes (Ptprb and
Sdc3) in mesangial cells, suggesting a possible autocrine
role. In addition there was extremely strong expression
of Ptprb in the glomerular endothelial cells, strongly
suggesting a paracrine function. It is also interesting to
note that PTN has been shown to disrupt calcium
dependent cell-cell adhesion and to promote epithelia to
mesenchyme transition [28]. Finally, it has also been
observed that PTN has strong antibacterial activity when
tested against a panel of gram-positive and gram-
negative bacteria [29], arguing that PTN is part of the
innate immune system.
Mfge8 (SED1) has many functions, including promot-
ing the phagocytic removal of apoptotic cells [30]. Peri-
cytes were previously identified as a major source of
Figure 3 (See legend on next page.)
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Figure 3 Molecular function, biological processes and candidate regulatory transcription factors and microRNAs in normal mesangial
cells. The central hexagons show some of the 172 genes with elevated expression in normal mesangial cells, compared to other cell types. The
surrounding squares show color coded molecular functions (light green), biological processes (dark green), transcription factors (light purple) and
microRNAs (dark purple), strongly associated with these genes. Lines show connections to linked genes. A. The cell adhesion biological process,
with associated genes, is highlighted in yellow. B. The locomotion biological process and associated genes is highlighted in yellow. For complete
lists of molecular functions, biological processes, transcription factors, microRNAs and other features see Additional file 3: Table S2.
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ered specialized pericytes. In Mfge8 knockout mice
tumor and retinopathy associated angiogenesis was
reduced [31]. It is also interesting to note that Mfge8 has
been shown to potentiate PDGFRB signaling [32].
The final robustly expressed growth factor gene with
mesangial cell elevated expression was Gdf10, which is a
member of the Tgf-β superfamily and is closely related
to Bmp3.
Receptors
The screen of the microarray data revealed a large num-
ber of receptor encoding genes with elevated mesangial
expression. The top dozen, ranked according to expres-
sion levels, were Itga8, Agtr1a, Pdgfrb, Itga4, S1pr3,
Trpc1, Il2rg, Ptger4, Pla2r1, Lphn3, P2rx1 and Tlr4.
Itga8, (integrin alpha8) has been previously shown to
have glomerular expression that is restricted to the
mesangial cells, providing another historical validation
of the microarray dataset. The Agtr1a gene encodes a re-
ceptor for angiotensin, a potent vasopressor hormone.
Agtr1a mutant mice show hypertrophy of the juxtaglo-
merular apparatus and mild mesangial expansion [33].
Pdgfrb has previously been shown to be expressed in
mesangial cells, and the Pdfrb mutant mouse shows a
failure of mesangial cell development [34]. It is interest-
ing to note that mesangial cells also express Pdgfc at
robust levels, suggesting a possible autocrine function.
Pdgfc did not emerge in the screen for mesangial cell
enriched growth factors because it is also expressed in
other cell types.
The S1pr3 gene encodes a receptor for sphingosine-1-
phosphate. It has been shown to be expressed by macro-
phages and to play a role in their recruitment during
inflammation and atherosclerosis [35]. Reports have also
linked S1pr3 signaling to fibrosis [36].
The Mrc1 receptor binds the surfaces of pathogenic
viruses and bacteria, facilitating their engulfment. It is
similar, therefore, in function to the secreted MFGE8,
which also promotes phagocytosis. Another receptor
associated with a macrophage function is IL2RG, a com-
mon subunit for the receptors of a variety of interleu-
kins. In addition the mesangial cells showed a high level
of expression of Tlr4, which encodes a member of the
Toll-like receptors. These are single transmembrane
receptors that have a key role in the innate immunesystem, and are generally found on immune cells. Tlr4
was previously shown to be expressed by mesangial cells,
and to contribute to antibody mediated glomeruloneph-
ritis through the production of CXC cytokines [37]. The
observed expression of S1pr3, Mrc1, Il2rg and Mfge8 by
mesangial cells serves to better define their anti-bacterial
macrophage like character.
Several TRPC receptors were expressed at elevated
levels in mesangial cells, including TRPC1, TRPC4 and
TRPC6. They belong to the transient receptor potential
super family of cation channels that have been impli-
cated in receptor and store-operated calcium entry, and
cell death, as well as functioning as sensors for heat,
cold, stretch, and osmotic changes.
The P2RX1 receptor functions in mediating synaptic
transmission from neurons to smooth muscle, and driv-
ing vasoconstriction. The PTERG4 receptor has the op-
posite effect. It is a receptor for prostaglandin E2 and
can induce smooth muscle relaxation.
db/db mesangial cells
We next sought to better define the protective and
pathogenic gene expression changes that occur in
mesangial cells as a function of diabetic nephropathy.
We used the db/db mouse model, which has a mutation
in the leptin receptor gene and as a result suffers obesity,
diabetes and diabetic nephropathy [38]. We generated
db/db mice that carried the Meis1-GFP transgene.
At the age of seven months the db/db mice showed
significant proteinuria, with albumin levels of 994±245
(μg/ml/24hrs), compared to 281±67 for wild type
(p=0.0036). The db/db mice also showed dramatic glyco-
suria, with glucose levels of 7,580±1,009 mg/dL, com-
pared to 78±6 for wild type. Hematoxylin and eosin
staining showed striking glomerular hypertrophy
(Figure 4A,B), and Masson’s trichome stain indicated
elevated levels of collagen deposition in the glomeruli of
db/db mice (Figure 4C,D). Further, Periodic acid-Shiff
(PAS) staining showed clear mesangial expansion in db/
db mice (Figure 4E,F).
The mesangial cell gene expression data from bio-
logical triplicates of wild type and db/db mice was ana-
lyzed, identifying 184 probesets, with 105 up-regulated
and 79 down-regulated in db/db mesangial cells (Add-
itional file 4: Table S3). We used Toppgene to perform a
functional analysis of the list of genes up-regulated
Figure 4 Glomerular changes in db/db diabetic mice. Panels A, C and E are controls, and panels B, D and F are from db/db mice with
diabetic nephropathy. Panels A and B show histological sections stained with hematoxylin and eosin and demonstrate glomeruli hypertrophy.
Panels C and D are sections stained with Masson's trichrome stain. Note the increased staining (blue) indicating a higher level of collagen
deposition in the glomeruli of diabetic mice. Panels E and F are sections stained with Periodic acid-Schiff (PAS) and show mesangial expansion in
diabetic mice. All images are representative glomeruli at an original magnification of 200X.
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functions of mesangial cells in the pathogenesis of dia-
betic nephropathy, the top three molecular functions
were extracellular matrix binding, fibronectin binding
and laminin binding. Some of the other up-regulated
molecular functions of particular interest were Rac
GTPase binding, Rho GTPase activator activity, glyco-
protein binding, and metallopeptidase activity. The top
identified up-regulated biological processes were nega-
tive regulation of cell-substrate adhesion, and vascular
development. Others included regulation of cell prolif-
eration, which is potentially important in terms of
mesangial matrix expansion, immune response, muscle
cell differentiation and wound healing. For complete lists
see Additional file 5: Table S4. A cytoscape graphics view
of some of the up-regulated genes and associated mo-
lecular functions, biological processes, and candidate
regulating microRNAs is shown in Figure 5.
We then applied a more stringent screen, requiring at
least raw signal expression of 300 in three samples, to iden-
tify the most robustly expressed up-regulated mesangial cellgenes in db/db mice. Some of the more interesting of the
resulting 34 genes are described below.
Thrombospondin (Tsp1) showed the greatest fold up-
regulation (2.8 fold change) in mice with diabetic
nephropathy. TGFβ is primarily secreted as an inactive
procytokine that must be activated to bind to its recep-
tors. Thrombospondin plays an important role in this
activation process, with Tsp1 mutant mice showing an
inflammatory phenotype similar to that of Tgf-β mutant
mice [39,40].
TGFβ has been known for many years to play a major
role in renal fibrosis. Indeed, it has been argued that
most of the features of diabetic nephropathy, including
GBM thickening, matrix expansion, hypertrophy and
podocyte loss are the result of TGFβ signaling [41]. Fur-
ther, it has been known for some time that mesangial
cells produce thrombospondin [42], and high glucose can
up-regulate thrombospondin expression in both rat and
human mesangial cells [43]. Elevated TSP1 expression in
mesangial cells of human type-2 diabetic nephropathy
was previously demonstrated by immunohistochemical
Figure 5 Changing gene expression programs in mesangial cells of db/db diabetic nephropathy mice. The red hexagons show some of
the genes up-regulated in mesangial cells of db/db diabetic mice. The dark green squares show biological processes, and light green molecular
functions, and purple a microRNA, with lines showing links to related genes.
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itional historic validation of the current study. The gene
we identified with the greatest up-regulaton, Tsp1, has
already been shown to play an important role in diabetic
nephropathy.
The only collagen gene observed to change signifi-
cantly in expression was Col12a1, which was up-
regulated almost two fold in db/db mice. It is interesting
that none of the Col4 subunit genes showed a change in
expression, although their upregulation in diabetic
nephropathy has been previously reported [44]. This
could be reconciled by a decreased rate of collagen deg-
radation in db/db glomeruli [45]. There is also evidence
that renal fibroblasts, associated with fibrosis, might be
an important source of the increased COL4 [46].
Similarly, there was no increased transcription of PKC
genes in the db/db mesangial cells, although previousreports have documented increased PKC activation as
well as total PKC levels in mesangial cells treated with
glucose [47]. Again, the likely explanation is a change in
PKC turnover.
Emcn, also up-regulated, encodes a mucin like sialogly-
coprotein “that interferes with the assembly of focal
adhesions complexes and inhibits the interaction be-
tween cells and the extracellular matrix” (EMCN Gene
Cards) [48]. Other up-regulated genes associated with
cell adhesion and the extracellular matrix included
Mmp2 (matrix metallopeptidase 2), and Lgals1 (lectin,
galactose binding). Other ECM related up-regulated
genes, but with raw expression levels below 300,
included Fat4, Fblim1, Spon2, Lgals3bp, Adam12, and
Itga6.
The annexin ANXA3 was also up regulated in db/db
mesangial cells. ANXA3 has been linked to phagocytosis
Figure 6 (See legend on next page.)
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Figure 6 Immunostaining for validation of gene expression differences in db/db glomeruli. Protein levels were examined in C (control)
kidneys, panels A, C, E, G, I and K, as well as DN (diabetic nephropathy) kidneys, panels B, D, F, H, J and L. Elevated glomerular expression was
observed in each case, as predicted by the microarray results. In addition, note the increased Collagen12a1 expression in the db/db tubules
(panels G and H).
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of phospholipase A2 and anti-coagulation. Ctsl encodes
cathepsin L, a lysosomal proteinase that has been shown
to play a major role in neovascularization.
We also observed up-regulation of ACER2, a cerami-
dase that cleaves ceramides to generate sphingosine,
which has the opposite effects on cell proliferation as
survival as sphingosine-1-phosphate. The up-regulated
Ppap2a gene, encoding phosphatidic acid phosphatase,
can dephosphorylate bioactive glycerolipids as well as
sphingolipids.
Elevated Acta2 expression, encoding smooth muscle
actin, has been noted previously in diabetic nephropathy
mesangial cells, and has been associated with differenti-
ation to a myofibroblast phenotype, believed causally
related to fibrosis. Of interest, TGFβ has been shown to
induce Acta2 in mesangial cells grown in culture [51].
We also observed up regulation of Flna, encoding fila-
min A, alpha, which is an actin binding protein involved
in cytoskeleletal remodeling to effect changes in cell
shape and migration. Another biologically related up-
regulated gene was Wdr1, which induces the disassembly
of actin filaments.
Of particular interest, the Decorin gene, Dcn, showed
up-regulation in db/db mesangial cells. Decorin has been
shown to interact with many extracellular matrix mole-
cules, including collagen, fibronectin and thrombospon-
din, as well as the growth factor TGFβ [52]. Expression
of Dcn has been shown to reduce TGFβ induced fibrosis
in many model systems [53]. Indeed, it has been shown
that decorin deficiency results in a much more severe
diabetic nephropathy in mice with with streptozotocin
induced diabetes [54]. This strongly suggests that the
over expression of Dcn observed in db/db mesangial
cells serves a protective function.
Validation
To confirm the microarray predicted expression changes
we performed immunohistochemisty, comparing wild
type glomeruli to those of db/db mice (Figure 6). The
results showed elevated db/db glomerular expression of
Thrombospondin, Annexin3a, Decorin, Collagen12a1,
Igfbp3 and AdamTS9, consistent with the microarray
results. As might be expected, there were typically
restricted regions of over expression. This facilitated de-
tection, since the overall fold change in expression com-
pared to wild type was generally relatively small. Of
interest, these genes also showed expression in flankingtubules, which was generally unchanged in the db/db
mouse, although increased somewhat for Decorin and
Collagen 12a1.Conclusions
In conclusion, we have FACS purified mesangial cells
from both normal and diabetic nephropathy model mice
and defined their in vivo gene expression states. The
results contribute to our molecular understanding of the
multifunctional character of mesangial cells, with their
gene expression signatures showing similarities to peri-
cytes, muscle cells, endothelial cells, neurons, and pha-
gocytes. The expression levels of all growth factor,
receptor and transcription factor genes were defined. In
addition we analyzed the changes in mesangial gene ex-
pression occurring as a function of diabetic nephropathy,
identifying genes involved in extracellular matrix, cell
division, vasculogenesis, and growth factor modulation.
New gene expression changes and biological pathways
were discovered, yielding a deeper understanding of the
disease process, and candidate targets for the develop-
ment of novel therapies.Additional files
Additional file 1: Table S1. List of 172 genes with elevated expression
in normal mesangial cells compared to other renal compartments. Fold
change shown is relative to renal vesicles.
Additional file 2: Figure S1. Heatmap showing genes with elevated
expression in normal mesangial cells. Expression patterns of 172 genes
with up-regulation in mesangial cells are compared across multiple renal
compartments, including cap mesenchyme, renal vesicle, total renal
cortex, podocytes, endothelial cells and renal capsule. Red indicates high,
yellow represents intermediate and blue indicates low gene expression
level. This figure can be zoomed to visualize individual gene names.
Additional file 3: Table S2. Functional analysis of genes with elevated
expression in normal mesangial cells. The top molecular functions,
biological processes, cellular components, evolutionarily conserved
transcription factor binding sites, microRNAs and diseases associated with
the list of 172 genes showing elevated mesangial cell expression. For
example, the first molecular function is store-operated calcium channel
activity. There are seven genes associated with this function and three of
them (Trpc1, Trpc4 and Trpc6) show elevated expression in mesangial
cells, giving an uncorrected P-value of 0.000017. Functional analysis was
carried out with the ToppGene (http://toppgene.cchmc.org/) web tool.
Additional file 4: Table S3. Genes with altered expression in diabetic
nephropathy mesangial cells. The left column lists the Affymetrix
probeset IDs. For some genes there are multiple probesets. Column B
shows fold change, comparing wild type to db/db mutant. Column C
shows directionality of change, with down signifying lower in wild type.
The gene with the greatest fold change was Thrombospondin, which was
2.8 fold down in wild type compared to mutant.
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http://www.biomedcentral.com/1471-2369/13/70Additional file 5: Table S4. Functional analysis of genes up-regulated
in db/db diabetic nephropathy mesangial cells. The top molecular
function, biological processes, cellular components, evolutionarily
conserved transcription factor binding sites and diseases associated with
the genes showing up-regulation in db/db mesangial cells, as determined
with the ToppGene (http://toppgene.cchmc.org/) web tool.
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